PMC:7309518 / 699-1472 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":442,"end":453},"obj":"Body_part"},{"id":"T5","span":{"begin":535,"end":542},"obj":"Body_part"},{"id":"T6","span":{"begin":580,"end":593},"obj":"Body_part"},{"id":"T7","span":{"begin":598,"end":602},"obj":"Body_part"},{"id":"T8","span":{"begin":711,"end":723},"obj":"Body_part"},{"id":"T9","span":{"begin":728,"end":744},"obj":"Body_part"},{"id":"T10","span":{"begin":745,"end":756},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma65239"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma82780"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T2","span":{"begin":739,"end":744},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T18","span":{"begin":180,"end":183},"obj":"Disease"},{"id":"T19","span":{"begin":185,"end":202},"obj":"Disease"},{"id":"T20","span":{"begin":206,"end":214},"obj":"Disease"},{"id":"T22","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"T23","span":{"begin":298,"end":305},"obj":"Disease"},{"id":"T24","span":{"begin":322,"end":342},"obj":"Disease"},{"id":"T25","span":{"begin":347,"end":362},"obj":"Disease"},{"id":"T26","span":{"begin":418,"end":440},"obj":"Disease"},{"id":"T27","span":{"begin":520,"end":528},"obj":"Disease"},{"id":"T28","span":{"begin":657,"end":667},"obj":"Disease"},{"id":"T29","span":{"begin":694,"end":702},"obj":"Disease"}],"attributes":[{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0008054"},{"id":"A21","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0021167"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0010528"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0003569"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005851"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":598,"end":602},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T4","span":{"begin":728,"end":744},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":442,"end":453},"obj":"Chemical"},{"id":"T4","span":{"begin":473,"end":477},"obj":"Chemical"},{"id":"T5","span":{"begin":535,"end":542},"obj":"Chemical"},{"id":"T6","span":{"begin":557,"end":568},"obj":"Chemical"},{"id":"T7","span":{"begin":564,"end":568},"obj":"Chemical"},{"id":"T8","span":{"begin":580,"end":593},"obj":"Chemical"},{"id":"T9","span":{"begin":618,"end":622},"obj":"Chemical"},{"id":"T10","span":{"begin":711,"end":723},"obj":"Chemical"},{"id":"T11","span":{"begin":745,"end":756},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_33563"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":124,"end":131},"obj":"Species"},{"id":"51","span":{"begin":371,"end":376},"obj":"Species"},{"id":"54","span":{"begin":442,"end":453},"obj":"Chemical"},{"id":"55","span":{"begin":557,"end":568},"obj":"Chemical"},{"id":"56","span":{"begin":711,"end":723},"obj":"Chemical"},{"id":"57","span":{"begin":745,"end":756},"obj":"Chemical"},{"id":"61","span":{"begin":151,"end":174},"obj":"Disease"},{"id":"62","span":{"begin":185,"end":202},"obj":"Disease"},{"id":"63","span":{"begin":206,"end":214},"obj":"Disease"},{"id":"64","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"65","span":{"begin":307,"end":314},"obj":"Disease"},{"id":"66","span":{"begin":322,"end":342},"obj":"Disease"},{"id":"67","span":{"begin":347,"end":362},"obj":"Disease"},{"id":"68","span":{"begin":418,"end":440},"obj":"Disease"},{"id":"69","span":{"begin":520,"end":528},"obj":"Disease"},{"id":"70","span":{"begin":650,"end":667},"obj":"Disease"},{"id":"71","span":{"begin":694,"end":702},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:9606"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Tax:34205"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D005732"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D019158"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D005732"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D006017"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D000208"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D004679"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D009220"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:C000657245"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D000370"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D003389"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D008231"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:D019846"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:D001039"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":65,"end":72},"obj":"Sentence"},{"id":"T11","span":{"begin":73,"end":297},"obj":"Sentence"},{"id":"T12","span":{"begin":298,"end":414},"obj":"Sentence"},{"id":"T13","span":{"begin":415,"end":771},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":473,"end":477},"obj":"GlycoEpitope"},{"id":"T2","span":{"begin":613,"end":622},"obj":"GlycoEpitope"},{"id":"T3","span":{"begin":618,"end":622},"obj":"GlycoEpitope"}],"attributes":[{"id":"A1","pred":"glyco_epitope_db_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0059"},{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/AN0403"},{"id":"A3","pred":"glyco_epitope_db_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0059"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":22,"end":34},"obj":"Phenotype"},{"id":"T7","span":{"begin":206,"end":214},"obj":"Phenotype"},{"id":"T8","span":{"begin":298,"end":305},"obj":"Phenotype"},{"id":"T9","span":{"begin":307,"end":314},"obj":"Phenotype"},{"id":"T10","span":{"begin":347,"end":362},"obj":"Phenotype"},{"id":"T11","span":{"begin":657,"end":667},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0100614"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0041051"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"xt of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome, ganglioside antibodies against GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral nerve glycolipids was addressed. E"}